What you need to know: – Absci Company (ABSI), a pioneer in utilizing generative AI to find antibodies, and AstraZeneca, a world biopharmaceutical chief, in the present day introduced a collaboration to develop an AI-engineered antibody towards most cancers. – This partnership combines Absci's breakthrough Built-in Drug Creation™ platform with AstraZeneca's oncology experience, aiming to speed up the invention of […]
![Absci and AstraZeneca signal $247 million partnership to find AI-powered medicines to combat most cancers](https://shop4healthinsurance.org/wp-content/uploads/2023/12/Absci-labshot2-016vid-CROP11111-1024x574.jpg)